COMPASS Pathways plc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Act of 1934 the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
| COMPASS Pathways plc | |||
| Date: | February 29, 2024 | By: | /s/ Kabir Nath |
|---|---|---|---|
| Kabir Nath | |||
| Chief Executive Officer | |||
| (Principal Executive Officer) | |||
Pursuant to the requirements of the Securities Act of 1934, this Annual Report on Form 10-K has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Kabir Nath | Chief Executive Officer (Principal Executive Officer) | February 29, 2024 |
| Kabir Nath | ||
| /s/ Mary-Rose Hughes | Interim Chief Financial Officer(Principal Financial Officer and Principal Accounting Officer) | February 29, 2024 |
| Mary-Rose Hughes | ||
| /s/ George Goldsmith | Chair of Board of Directors | February 29, 2024 |
| George Goldsmith | ||
| /s/ David York Norton | Lead Director | February 29, 2024 |
| David York Norton | ||
| /s/ Annalisa Jenkins | Director | February 29, 2024 |
| Annalisa Jenkins, MBBS | ||
| /s/ Daphne Karydas | Director | February 29, 2024 |
| Daphne Karydas | ||
| /s/ Thomas Lönngren | Director | February 29, 2024 |
| Thomas Lönngren | ||
| Director | ||
| Ekaterina Malievskaia | ||
| /s/ Robert McQuade | Director | February 29, 2024 |
| Robert McQuade | ||
| /s/ Linda McGoldrick | Director | February 29, 2024 |
| Linda McGoldrick | ||
| /s/ Wayne Riley | Director | February 29, 2024 |
| Wayne Riley, M.D., MPH, M.B.A. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.